Clinical Trial Update: Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial (EMERGE) studied AXS-07 for acute treatment of migraine in adults with prior inadequate response to an oral CGRP inhibitor. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AXS-07

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Migraine | Phase 3 | Status: COMPLETED